GeneNews Ltd. (OTCMKTS:GNWSF) opened at $0.11 on Tuesday. GeneNews Ltd. has a fifty-two week low of $0.06 and a fifty-two week high of $0.39. The company has a debt-to-equity ratio of -0.59, a current ratio of 0.08 and a quick ratio of 0.05.
TRADEMARK VIOLATION WARNING: This piece was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/11/14/genenews-ltd-gnwsf-set-to-announce-quarterly-earnings-on-wednesday.html.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Receive News & Ratings for GeneNews Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.